HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Steven Grant Selected Research
Steven Grant Research Topics
Disease
115
Neoplasms (Cancer)
02/2023 - 07/2002
81
Leukemia
01/2021 - 01/2002
35
Multiple Myeloma
12/2022 - 11/2002
26
Melanoma (Melanoma, Malignant)
11/2013 - 08/2003
23
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 07/2003
21
Carcinoma (Carcinomatosis)
10/2013 - 03/2002
21
Mitochondrial Diseases (Mitochondrial Disease)
01/2013 - 01/2002
14
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2019 - 08/2009
13
Hematologic Neoplasms (Hematological Malignancy)
07/2020 - 11/2003
13
Myeloid Leukemia (Leukemia, Myelocytic)
12/2015 - 01/2002
12
Glioblastoma (Glioblastoma Multiforme)
01/2015 - 07/2003
11
Breast Neoplasms (Breast Cancer)
10/2013 - 12/2004
10
Glioma (Gliomas)
10/2014 - 08/2003
9
B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 05/2009
9
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2019 - 12/2002
9
Lymphoma (Lymphomas)
05/2017 - 07/2003
9
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2011 - 07/2004
8
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018 - 06/2010
6
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2023 - 12/2009
6
Infections
03/2011 - 07/2003
5
Prostatic Neoplasms (Prostate Cancer)
05/2012 - 01/2007
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 07/2002
4
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 12/2002
4
Ataxia Telangiectasia (Louis Bar Syndrome)
09/2015 - 04/2003
4
Renal Cell Carcinoma (Grawitz Tumor)
11/2013 - 07/2003
3
T-Cell Lymphoma (Lymphoma, T Cell)
01/2023 - 01/2015
3
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2017 - 10/2012
3
Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2014 - 09/2011
Drug/Important Bio-Agent (IBA)
59
Histone Deacetylase Inhibitors
IBA
01/2023 - 02/2002
38
Proteins (Proteins, Gene)
FDA Link
01/2020 - 01/2002
32
Phosphotransferases (Kinase)
IBA
12/2022 - 01/2002
29
Bortezomib (Velcade)
FDA Link
12/2022 - 10/2003
27
Vorinostat
FDA Link
01/2018 - 12/2003
24
alvocidib (flavopiridol)
IBA
01/2018 - 02/2002
22
Proteasome Inhibitors
IBA
06/2019 - 10/2003
21
Cyclin-Dependent Kinases (cdk Proteins)
IBA
03/2014 - 02/2002
20
Sorafenib (BAY 43-9006)
FDA Link
01/2015 - 10/2005
20
Interleukins
IBA
11/2013 - 08/2003
20
Caspases
IBA
02/2013 - 03/2002
19
Cytokines
IBA
01/2020 - 12/2003
19
Imatinib Mesylate (Gleevec)
FDA Link
01/2015 - 01/2002
19
7-hydroxystaurosporine (UCN 01)
IBA
05/2013 - 05/2002
17
Histone Deacetylases (Histone Deacetylase)
IBA
01/2016 - 07/2003
17
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2013 - 07/2003
15
Butyric Acid (Butanoic Acid)
IBA
01/2006 - 02/2002
13
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
04/2012 - 11/2002
13
Cytochromes c (Cytochrome c)
IBA
07/2007 - 01/2002
12
Drug Combinations
IBA
06/2017 - 11/2005
12
2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamide
IBA
04/2012 - 01/2002
11
venetoclax
IBA
02/2024 - 01/2018
11
Ceramides
IBA
07/2012 - 03/2005
9
carfilzomib
IBA
10/2019 - 06/2010
8
DNA (Deoxyribonucleic Acid)
IBA
03/2022 - 07/2003
8
obatoclax
IBA
10/2013 - 11/2009
7
ABT-737
IBA
12/2015 - 01/2007
7
Caspase 3 (Caspase-3)
IBA
06/2008 - 01/2002
6
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2022 - 07/2002
6
Cytarabine (Cytosar-U)
FDA Link
Generic
09/2015 - 05/2002
6
Lapatinib (GW572016)
FDA Link
01/2015 - 11/2009
6
Caspase 9
IBA
10/2013 - 05/2002
6
Interleukin-10 (Interleukin 10)
IBA
05/2012 - 05/2010
6
Cytotoxins (Cytolysins)
IBA
01/2012 - 02/2003
6
tanespimycin (17AAG)
IBA
03/2011 - 09/2003
6
Mitogen-Activated Protein Kinases
IBA
05/2010 - 01/2002
6
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
05/2010 - 01/2002
6
bryostatin 1
IBA
10/2006 - 05/2002
6
Protein Kinase C
IBA
03/2005 - 05/2002
5
Azacitidine (5 Azacytidine)
FDA Link
02/2024 - 02/2023
5
belinostat
IBA
01/2023 - 01/2008
5
AZD 6244
IBA
03/2016 - 03/2008
5
OSU 03012
IBA
10/2014 - 08/2006
5
Small Interfering RNA (siRNA)
IBA
09/2014 - 08/2004
5
AD 5
IBA
11/2013 - 06/2010
5
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
08/2012 - 01/2002
5
fludarabine
IBA
04/2012 - 12/2002
5
entinostat (MS 275)
IBA
09/2011 - 07/2003
5
Caspase 8 (Caspase-8)
IBA
03/2011 - 05/2002
5
Heat-Shock Proteins (Heat-Shock Protein)
IBA
05/2010 - 09/2003
5
NF-kappa B (NF-kB)
IBA
03/2010 - 09/2003
5
Mitogen-Activated Protein Kinase 3
IBA
11/2009 - 02/2005
5
U 0126 (UO 126)
IBA
11/2009 - 11/2002
4
Decitabine
FDA Link
02/2024 - 05/2023
4
Ligands
IBA
12/2022 - 12/2003
4
Panobinostat
IBA
10/2021 - 04/2012
4
Apoptosis Regulatory Proteins
IBA
08/2017 - 02/2006
4
romidepsin (FK228)
FDA Link
01/2017 - 01/2008
4
Valproic Acid (Depakote)
FDA Link
Generic
05/2014 - 08/2009
4
Endoplasmic Reticulum Chaperone BiP
IBA
03/2014 - 05/2010
4
Checkpoint Kinase 1
IBA
08/2012 - 12/2006
4
Roscovitine
IBA
01/2007 - 04/2003
3
RNA Polymerase II (RNA Polymerase B)
IBA
10/2019 - 04/2013
3
Enzymes
IBA
01/2016 - 06/2005
3
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2016 - 06/2005
3
Dasatinib (BMS 354825)
FDA Link
01/2015 - 05/2007
3
Rituximab (Mabthera)
FDA Link
11/2014 - 10/2006
3
Death Domain Receptors
IBA
10/2014 - 05/2010
3
Phosphodiesterase 5 Inhibitors
IBA
10/2014 - 03/2014
Therapy/Procedure
51
Therapeutics
02/2024 - 01/2003
11
Drug Therapy (Chemotherapy)
06/2014 - 02/2003
5
Radiotherapy
02/2012 - 07/2003